Professors Carl Philpott and Claire Hopkins, joint leaders of the landmark MACRO programme – the most extensive clinical investigation into the management of chronic rhinosinusitis to date – discuss how the results challenge long-held assumptions about the roles of antibiotics and surgery and consider the implications for patients, clinicians and future care pathways. Chronic rhinosinusitis is a common, chronic inflammatory condition that affects the paranasal sinuses and nasal passages.